[18F]DCFBC

N/A

Report date: 2025/11/27 15:47:58
NME

Base Information

Drug Name[18F]DCFBC
Drug Alias NameN-[N-[(S)-1,3-Dicarboxypropyl]Carbamoyl]-4-[18F]Fluorobenzyl-l-Cysteine[18F]DCFBC
ClassificationSmall moleculesRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Fluorine > 18F +[5] 
Mechanisms of ActionDiagnostic imaging enhancersProstate-Specific Membrane Antigen inhibitors
TargetsProstate-Specific Membrane Antigen
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesWashington UniversitySidney Kimmel Cancer Center
China Registration ClassN/A

Develop Information

Active CompaniesWashington UniversitySidney Kimmel Cancer Center
Inactive CompaniesNational Cancer Institute
Active IndicationsProstatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A